Table 2.
Outcome Measures for Delayed and Not Delayed Groups
| Delayed n (%N), N=62 | Not Delayed n (%N), N=121 | p-valueb | |
|---|---|---|---|
| Visual Acuity Change (ΔlogMAR) | – | – | 0.006* |
| ≤0.05 (Snellen equivalent, <3 letter loss, or gain) | 30 (48.4) | 84 (69.4) | – |
| >0.05 (Snellen equivalent, >3 letter loss) | 32 (51.6) | 37 (30.6) | |
| Visual Acuity (Snellen) at Study Visit | – | – | 0.322* |
| ≥20/40 | 15 (24.2) | 42 (34.7) | – |
| 20/50-20/200 | 38 (61.3) | 66 (54.5) | – |
| <20/200 | 9 (14.5) | 13 (10.7) | – |
| Optical Coherence Tomography Status | – | – | <0.001* |
| Better | 6 (9.7) | 31 (25.6) | – |
| Stable | 26 (38.8) | 78 (64.5) | – |
| Worse | 30 (48.4) | 12 (9.9) | – |
| Change in Intravitreal Agent | 4 (6.5) | 2 (1.7) | 0.084* |
| Recommended Follow-Up Interval, Mean (SD) | – | – | – |
| Difference in follow-up interval (weeks) | −1.94 (18.07) | −0.08 (2.86) | 0.011a |
Notes: *Pearson χ2 analysis, Fisher exact test; aPaired Student’s t-test; bA bolded p-value indicates that it has reached the authors’ standards for statistical significance (p<0.05).
Abbreviations: SD, standard deviation.